🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

14,283 results for “B” Clear

  1. rituximab combined with corticosteroids

    The First People's Hospital of Lianyungang

    Primary Membranous Nephropathy

    approved small molecule active

    1 trial

  2. ropivacaine

    The First People's Hospital of Lianyungang

    Injury of Upper Limb

    approved small molecule completed

    1 trial

  3. sIPV+DTaP+MMR

    BRIGHT MINDS BIOSCIENCES INC.

    Vaccine

    approved mab active

    1 trial

  4. saproterin dihydrochloride

    BioMarin Pharmaceutical Australia Pty Ltd

    Phenylketonuria

    approved small molecule completed

    1 trial

  5. semaglutide combined with metformin

    The First People's Hospital of Lianyungang

    Osteoporosis

    approved small molecule active

    1 trial

  6. silk suture

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Breast Cancer

    approved other completed

    1 trial

  7. sodium oxybate

    Jazz Pharmaceuticals Ireland Limited

    Sleep

    approved small molecule completed

    1 trial

  8. sodium zirconium cyclic silicate

    The First People's Hospital of Lianyungang

    Potassium Imbalance

    approved small molecule active

    1 trial

  9. sublingual nicotine

    BRIGHT MINDS BIOSCIENCES INC.

    Nicotine Dependence

    approved small molecule completed

    1 trial

  10. tasimelteon 20 mg capsule

    Vanda Pharmaceuticals Netherlands B.V.

    Non-24-Hour-Sleep-Wake Disorder

    approved small molecule completed

    1 trial

  11. telbivudine (ROADMAP)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hepatitis B, Chronic

    approved small molecule active

    1 trial

  12. telmisartan

    Boehringer Ingelheim

    Hypertension

    approved small molecule completed

    1 trial

  13. ticagrelor + ASA

    Peking University Third Hospital

    Cerebrovascular Accident

    approved small molecule completed

    1 trial

  14. tigecycline

    Wyeth is now a wholly owned subsidiary of Pfizer

    Appendicitis

    approved small molecule completed

    1 trial

  15. tiotropium 18 mcg

    Boehringer Ingelheim

    Pulmonary Disease, Chronic Obstructive

    approved small molecule completed

    1 trial

  16. tong-jiang granules

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Non-erosive Reflux Disease/Diarrheal Irritable Bowel Syndrome

    approved small molecule active

    1 trial

  17. transdermal nicotine replacement therapy

    BRIGHT MINDS BIOSCIENCES INC.

    Smoking

    approved small molecule active

    1 trial

  18. trastuzumab [Herceptin]

    Hoffmann-La Roche

    Gastric Cancer

    approved small molecule terminated

    1 trial

  19. turoctocog alfa

    Novo Nordisk A/S

    Congenital Bleeding Disorder

    approved small molecule completed

    2 trials

  20. umeclidinium 62.5 µg and vilanterol 25 µg

    Theravance Biopharma Ireland Umited

    COPD (Chronic Obstructive Pulmonary Disease)

    approved small molecule active

    1 trial

  21. vaccinated with Sabin IPV

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Polio

    approved mab completed

    1 trial

  22. valdecoxib

    Pfizer

    Pain, Postoperative

    approved small molecule completed

    1 trial

  23. varenicline

    BRIGHT MINDS BIOSCIENCES INC.

    Cigarette Smoking

    approved small molecule completed

    2 trials

  24. video capsule endoscopy

    Hospital Authority, Hong Kong

    Overt Obscure Gastrointestinal Bleeding

    approved other completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources